Jenburkt Pharma Share Price Target 2025, 2026, 2030, 2040, 2050

Jenburkt Pharmaceuticals is a pharmaceutical company working in the healthcare field for over 35 years. The company makes and sells different types of medicines and health products, such as creams, syrups, tablets, and more. It sells its products not only in India but also in 13 other countries, showing its presence in the international market. The company mainly focuses on making medicines for pain relief, fever, muscle relaxation, and other common health problems, aiming to help people live healthier lives both in India and around the world.

What is Jenburkt Pharmaceuticals Ltd BSE: JENBURPH?

Jenburkt Pharmaceuticals is an Indian company established in 1985 in Mumbai by Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta. The company sells medicines and health products. It has a factory in Gujarat and a research centre approved by the government. It makes medicines for pain, infections, diabetes, and general health, with well-known brands like Nervijen, Zixa, and Glucotrol. Its products are sold in 13 countries and used by many doctors and pharmacies. The company also supplies medicines to government hospitals and public organizations. It focuses on good quality and uses modern technology to make sure people get safe and affordable medicines.

Share price Target Tomorrow

The stock has faced much dearish trend over the past few months. Now the stock has started recovering and showing some bullish moves but this is not enough to invest in it. For the buying opportunity, you should analyse its fundamentals, and consider some multiple technical confirmations before investing in it.

Day	Minimum Price (Rs)	Maximum Price (Rs)
Tomorrow	-24	+45

Jenburkt Pharma share price Target 2025

The Company makes and sells medicines in India and other countries. It works with many suppliers and provides medicines to pharmacies around the world. It also supplies medicines to government offices, public hospitals, and other health organizations. The Company has a factory in Sihor, Gujarat. This factory follows health and safety rules set by the World Health Organization (W.H.O). It also has a research centre that is approved by the Indian government. In 2025, its share price target would be ₹1470, as per our prediction.

Its share price would be between ₹945 to ₹1470 in 2025, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	945	1470

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1090	1317
February	936	1174
March	945	1060
April	981	1189
May	1057	1230
June	1089	1256
July	1125	1187
August	1148	1221
September	1168	1258
October	1190	1280
November	1242	1345
December	1310	1470

Jenburkt Pharma share price Target 2026

It works to provide good healthcare by offering helpful treatments that everyone can access. The company’s goal is to help patients and make a positive impact on people’s lives. At the current time, it is a trusted name in the pharmaceutical industry. Today, it makes and sells medicines in India and many other countries. With a dedicated team, the company works with doctors, supplies medicines to hospitals, and sends products to different parts of the world to help improve health everywhere. In 2026, its share price target would be ₹1971, as per our analysis.

By our prediction, its share price would be between ₹1310 to ₹1971 in 2026.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2026	1310	1971

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1310	1512
February	1358	1535
March	1389	1574
April	1425	1590
May	1468	1624
June	1488	1674
July	1521	1690
August	1565	1724
September	1584	1756
October	1632	1787
November	1674	1825
December	1755	1971

Share price Target 2027

It has a modern factory in Sihor, Gujarat, that follows W.H.O standards. The factory is approved by several countries, which ensures high-quality products. The company also has a research team, approved by the Indian government, that works on improving and creating new products. These advanced facilities provide reliable, high-quality products to both local and global markets. In 2027, its share price target would be ₹2462, as per our prediction.

Its share price would be between ₹1755 to ₹2462 in 2027, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2027	1755	2462

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	1755	1990
February	1787	2038
March	1800	2054
April	1874	2170
May	1890	2188
June	1954	2245
July	2018	2278
August	2090	2300
September	2125	2342
October	2188	2378
November	2245	2400
December	2321	2462

Share price Target 2028

The quality, safety, and effectiveness of its products are very important for this company, and the companyis trying there best to do it. It has a strong quality management system to ensure that all products are made and delivered properly. The company is dedicated to making sure that each product is produced and supplied according to high standards, so people can trust that the products are safe, reliable, and effective. In 2028, its share price target would be ₹2948, as per our analysis.

By our prediction, its share price would be between ₹2321 to ₹2948 in 2028.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2028	2321	2948

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	2321	2490
February	2356	2530
March	2378	2567
April	2390	2584
May	2425	2600
June	2478	2633
July	2500	2678
August	2545	2710
September	2587	2745
October	2624	2790
November	2687	2842
December	2754	2948

Share price Target 2029

Their vision is to supply the best quality of medicines. They do this by combining careful research, smart use of resources, and expert knowledge to create high-quality medicines and healthcare products. They had a dedicated team for research, quality checks, and customer feedback. The goal is to improve health and safety, helping families around the world live better, healthier lives. In 2029, its share price target would be ₹3443, as per our prediction.

Its share price would be between ₹2754 to ₹3443 in 2029, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2029	2754	3443

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	2754	2968
February	2822	2990
March	2855	3025
April	2868	3090
May	2888	3125
June	2920	3154
July	2956	3184
August	2987	3254
September	3042	3278
October	3125	3300
November	3154	3345
December	3287	3443

Jenburkt Pharma share price Target 2030

The company is focused on giving every customer high-quality products and building trust. They are always finding new ways to improve, using technology and science to make products in areas like Orthopaedics, Dermatology, Gynaecology, Paediatrics, Dentistry, and more. Their team works hard to stay ahead, which is why they are well-known in these important areas. They also believe in being steady and reliable, making sure their products and services always work well. In 2030, its share price target would be ₹3939, as per our analysis.

By our prediction, its share price would be between ₹3287 to ₹3939 in 2030.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2030	3287	3939

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	3287	3475
February	3325	3500
March	3358	3542
April	3385	3578
May	3421	3641
June	3487	3687
July	3524	3700
August	3587	3742
September	3625	3781
October	3687	3810
November	3725	3858
December	3790	3939

Share price Target 2040

It has big clients, including government agencies, missionary hospitals, public companies, and more. It has a manufacturing plant in Sihor, Gujarat, that follows strict quality and safety standards. The company also has a Research & Development department approved by the Ministry of Science & Technology, Government of India, which helps create new healthcare services. The company serve both local and global markets. Its main goal is to provide affordable, high-quality healthcare products that can improve people’s lives. In 2040, its share price target would be ₹7453, as per our prediction.

Its share price would be between ₹6833 to ₹7453 in 2040, as per our analysis.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2040	6833	7453

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	6833	6958
February	6874	6988
March	6880	7025
April	6911	7054
May	6908	7078
June	6942	7120
July	6987	7187
August	7035	7245
September	7084	7287
October	7158	7300
November	7190	7341
December	7287	7453

Share price Target 2050

The company supplies its products to hospitals, government organisations, and public sector businesses. Its goal is to offer life-changing healthcare services. Recently, the company started a new branch called Jenburkt Wellness to help people with their physical and mental health, launching products like Zixa Strong, a natural pain relief product, and Nervijen D3 tablets. In 2050, its share price target would be ₹11933, as per our analysis.

By our prediction, its share price would be between ₹11266 to ₹11933 in 2050.

Year	Minimum Price (Rs)	Maximum Price (Rs)
2050	11266	11933

Month	Minimum Price  (Rs)	Maximum Price (Rs)
January	11266	11389
February	11287	11400
March	11298	11442
April	11340	11474
May	11401	11530
June	11432	11580
July	11454	11625
August	11490	11687
September	11555	11721
October	11598	11800
November	11656	11830
December	11757	11933

Should I buy Jenburkt Pharma stock?

Year	Minimum Price (Rs)	Maximum Price (Rs)
2025	945	1470
2026	1310	1971
2027	1755	2462
2028	2321	2948
2029	2754	3443
2030	3287	3939
2040	6833	7453
2050	11266	11933

The company has been around for over 35 years. It is well-known worldwide and focuses on making quality products. They also have a government-approved research centre, which helps them plan for the future. But the stock price has gone down recently. While it’s starting to recover, it’s a good idea to be careful if you’re thinking about short-term investments. If you’re interested in long-term growth and should analyse the market trends, as it has potential for future growth.

Jenburkt Pharma earning results

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales +	119	109	124	137	142	149
Expenses +	99	89	97	106	109	110
Operating Profit	20	20	27	30	33	39
OPM %	17%	18%	22%	22%	23%	26%
Other Income +	4	4	5	5	5	6
Interest	1	0	0	0	0	0
Depreciation	2	2	2	2	2	3
Profit before tax	21	22	30	33	35	42
Tax %	30%	24%	25%	25%	26%
Net Profit +	15	16	22	25	26	31
EPS in Rs	32.40	35.95	48.59	55.76	58.87	71.17
Dividend Payout %	25%	28%	25%	26%	26%

Key Metrics

TTM PE Ratio	PB Ratio	Dividend Yield	Sector PE	Sector PB	Sector Div Yld
14.66	3.18	1.47%	47.87	6.12	0.55%

Peers & Comparison

Stock	PE Ratio	PB Ratio	Dividend Yield
Jenburkt Pharmaceuticals Ltd	17.72	3.18	1.47%
Sun Pharmaceutical Industries Ltd	42.28	6.03	0.80%
Cipla Ltd	28.67	4.41	0.89%
Torrent Pharmaceuticals Ltd	63.93	15.45	0.89%

Is Jenburkt Pharma stock good to buy? (bull case & bear case)

Bull Case:

• Strong in the generics and medicine market.
• Good chances to grow in new markets.
• Investing in new medicines could lead to growth.
• Healthy profits and good financial health.
• Pays a dividend of 25.5%.
• Almost no debt and the company has reduced its debt.
• New product approvals could raise stock prices.

Bear Case:

• Sales have only grown 2.97% in the last five years.
• Depends on a few key products for most of its revenue.
• Expiring patents could reduce sales.

Conclusion

The company sells its products in several countries and has a safe, high-quality factory and a research centre approved by the government. The stock has had some ups and downs recently, it could do well in the future, especially in the generics market. If you’re thinking about investing, it’s important to be careful because the stock hasn’t done well in the short term. But if you’re looking for a long-term investment, it could be a good choice because of its focus on quality and growth.

FAQs